Abamune 300 Mg (Abacavir Sulphate)
$95.27 – $220.94Price range: $95.27 through $220.94RxRequired
-
United States dollar ($) - USD
-
Euro (€) - EUR
-
Canadian dollar ($) - CAD
| Pack Size | Price | Unit Price | Quantity | |
|---|---|---|---|---|
| 30 Tablet/s | $95.27 | $3.18 / tablet | ||
| 60 Tablet/s | $159.60 | $2.66 / tablet | ||
| 90 Tablet/s | $220.94 | $2.45 / tablet |
Add $199.00 to cart and get free shipping!
About Abamune 300 Mg (Abacavir Sulphate)
Medicine information
- Active ingredient
- Abacavir sulphate equivalent to abacavir
- Delivery time
- Typically 10–14 business days after dispatch to the United States, United Kingdom, Canada, and Australia; 12–18 business days to served European destinations; and 14–21 business days to other served destinations. These are estimates and customs or local carrier delays can extend delivery.
- Indication
- Treatment of HIV-1 infection in combination with other antiretroviral medicines.
- Manufacturer
- Cipla Ltd., Patalganga, Raigad, Maharashtra, India
- Strength
- 300 mg
- Dosage form
- Tablet
- Route
- Oral
Medicine overview
Abamune 300 mg is an oral antiretroviral medicine containing abacavir sulphate equivalent to 300 mg of abacavir. It is manufactured by Cipla Ltd. and is used as part of combination treatment for HIV-1 infection. Abacavir belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class. It reduces the ability of HIV to reproduce inside cells. Abacavir does not cure HIV and should be used together with other appropriate antiretroviral medicines as prescribed.
What it is used for
Abamune 300 mg is used with other antiretroviral medicines to treat HIV-1 infection. Combination antiretroviral therapy lowers the amount of HIV in the blood and helps preserve immune function. Abacavir should not be used by itself as complete HIV treatment. Consistent treatment is important because missed or interrupted therapy can reduce viral control and may complicate future treatment.
How it works
Abacavir is a nucleoside reverse transcriptase inhibitor. Inside cells, it is converted to an active form that interferes with HIV reverse transcriptase, an enzyme the virus needs to make copies of its genetic material. Incorporation of the active drug into viral DNA stops further DNA-chain formation. This limits HIV replication and, when abacavir is combined with other effective antiretroviral medicines, helps reduce the amount of virus in the body.
How it is taken
Abamune is taken by mouth as part of a combination antiretroviral regimen. Abacavir tablets can be taken with or without food. Take the medicine exactly as prescribed and avoid interrupting treatment without medical advice. If several doses have been missed or treatment has been stopped, contact the prescriber before restarting because restarting abacavir can be dangerous if a hypersensitivity reaction has occurred.
Important warnings
Abacavir can cause a serious and potentially fatal hypersensitivity reaction. HLA-B*5701 genetic screening should be performed before starting abacavir; people who test positive should not receive it. Warning symptoms can include fever, rash, nausea, vomiting, diarrhoea or abdominal pain, severe tiredness or general illness, shortness of breath, cough, or sore throat. Stop abacavir and obtain urgent medical assessment if hypersensitivity is suspected. Never restart abacavir after a suspected hypersensitivity reaction because a repeat reaction can be rapid and life-threatening. Tell the prescriber about liver disease, cardiovascular risk factors and all other medicines. Interactions of clinical importance include methadone and riociguat. Antiretroviral treatment can also be associated with immune reconstitution inflammatory syndrome, in which previously quiet infections or inflammatory conditions become symptomatic after immune recovery.
Side effects and monitoring
Common reported effects of abacavir include nausea, vomiting, headache, tiredness and sleep problems. A hypersensitivity reaction is the most important serious adverse effect and requires immediate medical assessment; symptoms commonly involve more than one body system and may include fever, rash, gastrointestinal symptoms, severe fatigue or respiratory symptoms. Severe allergic skin reactions, breathing or swallowing difficulty, and symptoms compatible with lactic acidosis or serious liver problems also require prompt medical attention. HIV viral load and other laboratory tests should be monitored as part of routine antiretroviral care.
Pregnancy
Abacavir may be used during pregnancy when it is part of an appropriate antiretroviral regimen. Current NIH pregnancy data do not show an increased risk of congenital abnormalities with first-trimester abacavir exposure, and pregnancy does not itself require an abacavir dose adjustment. HLA-B*5701 screening remains necessary before initiating abacavir. HIV treatment during pregnancy should be selected and monitored by an experienced healthcare professional.
Breastfeeding
Abacavir passes into breast milk. Infant-feeding recommendations for people with HIV depend on viral suppression, treatment adherence, local guidance and individual circumstances. Current U.S. guidance supports shared decision-making for people with sustained viral suppression who wish to breastfeed, while recognizing that transmission risk is less than 1% but not zero. Discuss feeding options and antiretroviral treatment with the HIV care team.
Food, drink and interactions
Alcohol can increase overall exposure to abacavir by reducing its elimination from the body. Discuss alcohol use with the prescriber, particularly if there is liver disease or regular/heavy alcohol consumption.
Food and drink
Abacavir tablets can be taken with or without food. Food may delay absorption but does not meaningfully change overall abacavir exposure. No special diet is generally required unless advised for another medical reason.
Frequently asked questions
Why do I need an HLA-B5701 test before starting abacavir?
The test identifies people at particularly high risk of a serious abacavir hypersensitivity reaction. Anyone who tests positive for HLA-B5701 should not start abacavir.
What symptoms could mean I am having an abacavir hypersensitivity reaction?
Fever or rash together with symptoms such as nausea, vomiting, diarrhoea, abdominal pain, severe tiredness, general illness, shortness of breath, cough or sore throat can indicate hypersensitivity. Seek urgent medical advice if a reaction is suspected.
Can I restart Abamune after stopping it?
Do not restart it on your own. Abacavir must never be restarted after a suspected hypersensitivity reaction, and if treatment was interrupted for another reason, speak with the prescriber before restarting.
Can I take Abamune with food?
Yes. Abacavir tablets can be taken with or without food.
Does Abamune cure HIV?
No. Abacavir helps control HIV when used as part of effective combination antiretroviral therapy, but it does not eliminate HIV from the body.
Can I drink alcohol while taking abacavir?
Discuss alcohol use with your healthcare professional. Alcohol can slow the elimination of abacavir and increase overall exposure to the medicine.
Can Cheap Generic Med ship Abamune to the United States?
Cheap Generic Med serves the United States under its international shipping model. Delivery is typically estimated at 10–14 business days after dispatch, but customs or carrier delays may extend transit; prescription and personal-import requirements may also apply.
Will my Cheap Generic Med order have tracking?
Under the standard fulfilment model, tracked international shipping is used and a tracking number should be provided after dispatch. Carrier systems can take 24–72 hours to begin showing movement.
Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.
| Active Ingredients | Abacavir Sulphate |
|---|---|
| Manufacturer | Cipla, India |
| Packaging | Qty |
| strength | 300mg |
| Delivery Time | 6 To 15 days |

Reviews
There are no reviews yet.